|
|
 |
Human Immunodeficiency Virus (HIV) Research Program: DOD and USAMRMC
|
The Human Immunodeficiency Virus (HIV) research program emphasizes prevention of disease transmission and measures to prevent disease progression. This includes vaccines for prevention, prevention education of service members, disease assessment, and intervention strategies. Research will be conducted to maximize the use of unique characteristics of military populations such as the broad cross-sectional nature of the community, their potential to be deployed to almost any area of the world, and the total susceptibility of the group to the disease.
Deadline:ontinuous. This is an open announcement scheduled to close on September 30, 2003. Many of the programs and areas of interest may not have funding readily available. The PI is strongly encouraged to explore USAMRMC interest by submitting a preliminary research proposal (preproposal). Preproposals may be submitted at any time on any research topic describing a specific idea or project to USAMRMC. Usually, the PI should receive a decision letter or electronic mail on the preproposal within 30 to 60 days of submission.
Eligibility:ontracts, grants and cooperative agreements are awarded to organizations, not individuals. A principal investigator (PI) must submit a proposal, and be employed by a university, college, nonprofit research institute, or commercial firm in order to receive support. Unrestricted citizenship.
Sponsor:United States Department of Defense (DOD); Department of the Army U.S. Army Medical Research and Materiel Command (USAMRMC);
Broad Agency Announcement (BAA 02-1).
Sponsor Ref. No.:BAA 02-1
Contact Details: Cheryl Miles, U.S. Army Medical Research Acquisition Activity, Attn: BAA 02-1, 820 Chandler Street, Fort Detrick, Maryland, 21702-5014, USA.
Tel: +1 (301) 619-7148; Fax: +1 (301) 619-2243; E-mail: [email protected]
URL for more information:http://www-usamraa.army.mil/pages/Baa_Paa/baa_02_1.cfm |
| Was this article helpful to you? |
 ?0%???? ?0%
|
|
Back
|
|
|
|
